Iressa, also known by its generic name gefitinib, is a medication commonly used in the treatment of non-small cell lung cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the action of a protein called epidermal growth factor receptor (EGFR) that is involved in the growth and spread of cancer cells.

Iressa is typically prescribed for patients with advanced or metastatic non-small cell lung cancer that has not responded to other treatments. It is often used in combination with other cancer medications or therapies to improve outcomes and quality of life for patients.

As with any medication, Iressa may cause side effects in some individuals. Common side effects may include diarrhea, skin rash, nausea, and fatigue. It is important to discuss any side effects with your healthcare provider, as they may be able to provide recommendations for managing them.

It is important to take Iressa exactly as prescribed by your healthcare provider. Do not adjust your dose or stop taking the medication without consulting your doctor first. Your healthcare provider will monitor your progress and may adjust your treatment plan as needed.

If you have any questions or concerns about Iressa or your treatment plan, do not hesitate to reach out to your healthcare provider. They are there to support you and help you navigate your cancer treatment journey.

Overall, Iressa is an important medication in the treatment of non-small cell lung cancer and has shown to be effective in improving outcomes for many patients. By working closely with your healthcare team and following their guidance, you can maximize the benefits of this medication and improve your overall quality of life.